About Man’s Best Friends Therapeutics
Man’s Best Friends Therapeutics is a company based in Ambler (United States) founded in 2008.. Man’s Best Friends Therapeutics has raised $2.7 million across 6 funding rounds from investors including National Science Foundation and Ben Franklin Technology Partners. Man’s Best Friends Therapeutics offers products and services including T-Max™ DNA Vaccine Platform. Man’s Best Friends Therapeutics operates in a competitive market with competitors including Sana Biotechnology, Janux Therapeutics, Carisma Therapeutics, GigaGen and Kronos Bio, among others.
- Headquarter Ambler, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mbf Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.7 M (USD)
in 6 rounds
-
Latest Funding Round
$256 K (USD), Grant
Jan 01, 2022
-
Investors
National Science Foundation
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Man’s Best Friends Therapeutics
Man’s Best Friends Therapeutics offers a comprehensive portfolio of products and services, including T-Max™ DNA Vaccine Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for creating DNA vaccines against animal infectious diseases.
Funding Insights of Man’s Best Friends Therapeutics
Man’s Best Friends Therapeutics has successfully raised a total of $2.7M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $256 thousand completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $256,000
-
First Round
First Round
(15 Mar 2010)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Grant - Man’s Best Friends Therapeutics | Valuation |
investors |
|
| Sep, 2020 | Amount | Seed - Man’s Best Friends Therapeutics | Valuation |
investors |
|
| May, 2019 | Amount | Seed - Man’s Best Friends Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Man’s Best Friends Therapeutics
Man’s Best Friends Therapeutics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include National Science Foundation and Ben Franklin Technology Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Technology ecosystem growth is supported in Southeastern Pennsylvania.
|
Founded Year | Domain | Location | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Man’s Best Friends Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mans Best Friends Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Man’S Best Friends Therapeutics Comparisons
Competitors of Man’s Best Friends Therapeutics
Man’s Best Friends Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sana Biotechnology, Janux Therapeutics, Carisma Therapeutics, GigaGen and Kronos Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer treatment are developed to target solid tumors.
|
|
| domain | founded_year | HQ Location |
Chimeric antigen receptor macrophages are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of cancer and autoimmune diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Man’S Best Friends Therapeutics
Frequently Asked Questions about Man’s Best Friends Therapeutics
When was Man’s Best Friends Therapeutics founded?
Man’s Best Friends Therapeutics was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Where is Man’s Best Friends Therapeutics located?
Man’s Best Friends Therapeutics is headquartered in Ambler, United States. It is registered at Ambler, Pennsylvania, United States.
Is Man’s Best Friends Therapeutics a funded company?
Man’s Best Friends Therapeutics is a funded company, having raised a total of $2.7M across 6 funding rounds to date. The company's 1st funding round was a Seed of $605K, raised on Mar 15, 2010.
What does Man’s Best Friends Therapeutics do?
Founded in 2008, Mans Best Friends Therapeutics operates from Ambler, United States, within the animal health sector. Gene-based checkpoint inhibitors and immune-modulators are developed for treating cancer and infectious diseases in companion animals. Proprietary viral and non-viral delivery systems are employed to enhance vaccine efficacy. Focus is placed on the companion animal market, with ongoing advancements in therapeutic options.
Who are the top competitors of Man’s Best Friends Therapeutics?
Man’s Best Friends Therapeutics's top competitors include Janux Therapeutics, Kronos Bio and Sana Biotechnology.
What products or services does Man’s Best Friends Therapeutics offer?
Man’s Best Friends Therapeutics offers T-Max™ DNA Vaccine Platform.
Who are Man’s Best Friends Therapeutics's investors?
Man’s Best Friends Therapeutics has 2 investors. Key investors include National Science Foundation, and Ben Franklin Technology Partners.